Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

What if I’m doomed to live with this forever? Kendra Johnson thought as she looked in the mirror. The Spokane, Washington, ...

Q. Is there any cure for psoriasis? A. There’s no cure for psoriasis yet, but there are many ways to get relief from the symptoms of this troublesome disease. Psoriasis is one of the most ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

For example, in a small 2021 study of 25 people in Bangkok with nail psoriasis, roughly 35% also had a fungal infection in the nails. People with nail psoriasis develop a telltale pattern of ...